Abstract
Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Anti-Infective Agents in Medicinal Chemistry
Title: Sterols and Triterpenoids with Antiviral Activity
Volume: 8 Issue: 3
Author(s): T. Rezanka, L. Siristova and K. Sigler
Affiliation:
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Abstract: Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Export Options
About this article
Cite this article as:
Rezanka T., Siristova L. and Sigler K., Sterols and Triterpenoids with Antiviral Activity, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (3) . https://dx.doi.org/10.2174/187152109788680207
DOI https://dx.doi.org/10.2174/187152109788680207 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
The Cell-Type Specificity and Endosomal Escape of Cell-Penetrating Peptides
Current Pharmaceutical Design Advanced Micro-Nano-Bio Systems for Future Targeted Therapies
Current Nanoscience Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Thermosensitive Liposomes in Cancer Therapy
Recent Patents on Biomedical Engineering (Discontinued) ABC Transporters as Potential Targets for Modulation of Drug Resistance
Mini-Reviews in Medicinal Chemistry Lung Cancer Chemotherapy, New Treatment and Related Patents
Recent Patents on Anti-Cancer Drug Discovery Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms
Current Drug Targets Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
Current Cancer Drug Targets DNA Repair in Normal and Cancer Stem Cells, with Special Reference to the Central Nervous System
Current Medicinal Chemistry Integrated Differential Regulatory Analysis Reveals a Novel Prognostic 36-Gene Signature for Gastric Cancer in Asian Population
Combinatorial Chemistry & High Throughput Screening Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets Rho GTPase Effector Functions in Tumor Cell Invasion and Metastasis
Current Drug Targets ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Pomegranate Extracts and Cancer Prevention: Molecular and Cellular Activities
Anti-Cancer Agents in Medicinal Chemistry Innovative Cancer Treatments that Augment Radiotherapy or Chemotherapy by the Use of Immunotherapy or Gene Therapy
Recent Patents on Anti-Cancer Drug Discovery CYP17 Inhibitors for Prostate Cancer Treatment – An Update
Current Medicinal Chemistry Antioxidant, Pro-Oxidant and Other Biological Activities of Sesquiterpenes
Current Topics in Medicinal Chemistry Discovery of BRM Targeted Therapies: Novel Reactivation of an Anticancer Gene
Letters in Drug Design & Discovery